Novo Nordisk boasts 45 million customers using their drug Ozempic, which has caused a revolution in weight-loss treatment.

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

He also published one of the first case series that found semaglutide, the active ingredient in Ozempic, to effectively reduce alcohol consumption among six people with addiction. (The drug ...

But while basic research continues slowly, a flood of Ozempic competitors are rushing to market. Some of them may work even better than Ozempic at causing weight loss. Mounjaro, from a company ...

Between being a cast member on The Real Housewives of New Jersey, starring in the latest season of the hit competition show ...

Ozempic has skyrocketed in popularity as both a diabetes medication and a weight loss aid, but a growing number of patients are reporting an unexpected and puzzling side effect. Some users have ...

The US-based Australian sleep apnoea device giant has exceeded expectations with strong second quarter numbers.

Ozempic (semaglutide) is a subcutaneous injection used in people with type 2 diabetes. It may cause mild side effects, such as abdominal pain, or more serious side effects, such as diabetic ...

Are you a print subscriber? Activate your account. By Tim Nudd - 14 min 58 sec ago 2 hours 35 min ago By Parker Herren - 2 hours 48 min ago By Brian Bonilla - 2 hours 48 min ago By Jean-Paul ...